Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
Dryad hosts a systematic review and meta-analysis of 13 clinical studies comparing gonadotropin-releasing hormone antagonists to standard androgen suppression therapy for advanced prostate cancer. The analysis, led by Frank Kunath and an international team including the German Cochrane Centre, extracted data on outcomes like overall mortality, treatment failure, and prostate-specific antigen progression up to March 2015. It includes safety data from non-randomized studies and assesses evidence quality using the GRADE framework.
Dataset consists of aggregated meta-analysis results, not raw patient-level data; primary use is for evidence synthesis. Licensed under CC0 1.0.